ALEMBIC
Back to Balance Sheet
|
ALEMBIC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹54 Cr | ₹53 Cr | ₹43 Cr | ₹68 Cr | ₹53 Cr |
What is the latest Total Non-Current Liabilities ratio of ALEMBIC ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹54 Cr |
Mar2024 | ₹53 Cr |
Mar2023 | ₹43 Cr |
Mar2022 | ₹68 Cr |
Mar2021 | ₹53 Cr |
How is Total Non-Current Liabilities of ALEMBIC Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹54 Cr | 1.98 | |
Mar2024 | ₹53 Cr | 23.76 | |
Mar2023 | ₹43 Cr | -36.78 | |
Mar2022 | ₹68 Cr | 28.72 | |
Mar2021 | ₹53 Cr | - |
Compare Total Non-Current Liabilities of peers of ALEMBIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC | ₹2,513.6 Cr | 1.8% | -6.4% | -29.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,218.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,158.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹126,710.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,586.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,496.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
ALEMBIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC | 1.8% |
-6.4% |
-29.4% |
SENSEX | 1.6% |
2.1% |
2.6% |
You may also like the below Video Courses